License of Product. A. ULC hereby grants to ULI an exclusive, worldwide and perpetual license to use the Technology for all travel-related applications (but for no other applications whatsoever) (the "License"), to use and duplicate the materials described in the above referenced patent application together with all materials related thereto and all copyrights, patents, trade secrets, intellectual and other proprietary rights therein that may presently exist with respect thereto, including without limitation, source and object code, file and screen layouts, listings, reference manuals, operating instructions, procedures, documentation and methodology developed now or in the future in connection therewith (such software and related materials and items hereinafter being collectively referred to as the "Technology").
License of Product. 4.1 Depomed hereby grants to BLS an exclusive license in the Territory under the Patent Rights, Know-How and Technical Information, with the right, subject to Section 4.3, to grant sublicenses of the same scope as the license granted by this Agreement, or to THE SYMBOL [***] IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED appoint a Distributor, to Manufacture and Market 500mg Product in, and import 500mg Product into, the Territory.
License of Product. 10.1 APP hereby grants to RHEI an exclusive license in the Territory under the Patent Rights and Know How to develop, have developed, apply for and obtain Regulatory Approval, use, Market and import Licensed Product, with the right to grant sublicenses to Affiliates of the same scope as the license granted by this Agreement, (except that any Affiliate shall have no right to grant further sublicenses), to develop, have developed, apply for and obtain Regulatory Approval, use, Market and import Licensed Product in the Territory. RHEI and its Affiliates shall also have the right to grant co-promotion rights to third parties in the Territory. 10.2 APP hereby grants to RHEI the right to use the Clinical Information and Data generated by or on behalf of APP and its Affiliates (as provided in Section 4.2) for the purpose of obtaining Regulatory Approval of the Licensed Product in the Territory. 10.3 RHEI shall have the right to Market and sell Licensed Product under any trademark or trademarks that RHEI chooses and has the legal right to use, whether now or hereafter acquired or developed. At RHEI's sole discretion, RHEI shall have the right to use trademark(s) for Licensed Product which is/are filed for and owned by APP, if any, and APP hereby grants to RHEI all rights and licenses to use such APP product trademark(s) in connection with Licensed Product in the Territory. Upon the written request of APP, RHEI will, in addition to a product trademark, in any event use a line trademark proprietary to APP that is registered and owned by APP in the People's Republic of China (which may, but need not be, "Biochronomer"), which trademark shall be displayed in a prominent position (but in a size and prominence less than the primary trademark selected by RHEI) on all promotional and Marketing materials for the Licensed Product. Except as expressly set forth herein, nothing herein shall be deemed to give either party any rights to the trademarks of the other party. 10.4 RHEI shall make, or shall cause an Affiliate to make, the first commercial sale of the Licensed Product in each country in the Territory within 90 days following the grant of Regulatory Approval and any other necessary Applicable Permits, including, without limitation, pricing approval if required in that country. [***] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
License of Product. Lenstec agrees to license to STAAR on a ------------------- semi-exclusive basis, as set forth below, the Product for re-sale, and to manufacture and supply the Product for STAAR, on the terms set forth in this Agreement. Lenstec, pursuant to an existing agreement with Santen Pharmaceutical Co., Ltd., a Japanese corporation ("Santen") is obligated to offer to Santen for sale under Santen's proprietary brand, any product produced by Lenstec. Lenstec agrees to sell the Product only to STAAR, its affiliates and Santen during the term of this Agreement. Lenstec agrees that during the term of this agreement it will not sell a three piece Hema/Acrylic copolymer lens with haptics made from any suitable material to anyone other than the parties named herein in the respective territories named in paragraph 1.2 and 1.5.
License of Product. 11.1 DepoMed hereby grants to BLI an exclusive license in the Territory under Patent Rights, Know-How and Technical Information, with the right to grant sublicenses of the same scope as the license granted by this Agreement, (except that any sublicensee shall have no right to grant further sublicenses), to develop, have developed, Manufacture, Market and import Licensed Product in the Xxxxxxxxx.
License of Product. APEX hereby grants to Travel Dynamics a worldwide, nonsublicensable (except that Travel Dynamics may grant a sublicense as necessary to permit an independent contractor to modify the Product on behalf of Travel Dynamics as permitted hereunder), nontransferable (except in connection with the permitted transfer or assignment of this Agreement) irrevocable (except in the event of non-payment by Travel Dynamics of sums required to be paid by Travel Dynamics under Paragraphs 2.05, 2.08, and 2.12 or other material breach of this Agreement by Travel Dynamics), royalty free (except for payments required to be made by Travel Dynamics hereunder) nonexclusive license to use and modify the Product (except for Licensed Work embodied in the Product). Travel Dynamics agrees to provide a copy of the sublicense agreement to APEX for approval prior to making it available to their customers. Travel Dynamics also agrees to gain APEX approval for any changes to the sublicense agreement after it goes in force and during the tenure of this agreement.
License of Product
